RACHEL BALKEMA: Open Payments
NPI 1356776207 · MUSKEGON, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$634 in 31 payments from 12 companies in 2025. Trend: 2023 $1,801 · 2024 $764 · 2025 $634
Food & beverage: $634
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $309 |
| Lundbeck LLC | 4 | $81 |
| Genentech USA, Inc. | 2 | $53 |
| Teva Pharmaceuticals USA, Inc. | 2 | $39 |
| Novartis Pharmaceuticals Corporation | 1 | $31 |
| MicroTransponder, Inc. | 1 | $23 |
| Aucta Pharmaceuticals, Inc. | 1 | $20 |
| UCB, Inc. | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
| Celgene Corporation | 1 | $15 |
Products named: QULIPTA, VYEPTI, Ocrevus Zunovo, KESIMPTA, BOTOX, AJOVY, Motpoly XR, Briviact.
Industry payments across MI — which companies pay providers there.
